Can I Reuse the EUPATI Material?

We license all information on www.eupati.eu,  www.toolbox.eupati.eu, and learning.eupati.eu under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license.

What am I allowed to do?

By licensing our work with the CC BY-NC-SA 4.0 license it means that you may:

  • Share — copy and redistribute the material in any medium or format.
  • Adapt — remix, transform, and build upon the material.

However, when you use EUPATI materials , you must:

  • Give appropriate credit, including the name of the creator and attribution parties, a copyright notice, a license notice, a disclaimer notice, and a link to the material. Example Statements for providing proper attribution are given below.
  • Indicate if you modified the material and retain an indication of previous modifications.
  • If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original (CC BY-NC-SA 4.0).
  • Avoid applying legal terms or technological measures that legally restrict others from doing anything the license permits. You can do this in any reasonable manner, but not in any way that suggests EUPATI endorses you or your use.

How to give Appropriate Credit – Example Statements

What am I NOT allowed to do?

Use the licensed material for commercial purposes. Commercial use means primarily intended for or directed towards commercial advantage, payment, or monetary compensation, which would be a violation of the license. Three examples of commercial and non-commercial use are given below.

Examples of non-commercial and commercial use

Creative Commons defines non-commercial use as – “not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is Non-Commercial provided there is no payment of monetary compensation in connection with the exchange.” As such please see the below three examples of use and EUPATI’s opinion on these.

  • Example 1: ‘My company is recruiting for a clinical trial and we’d like to point our participants to EUPATI material as a resource to learn about how medicines development works, or we’d like to use EUPATI material as a base to develop material to inform participants about medicines development.’ – EUPATI’s opinion: Non-commercial.
  • Example 2: ‘I want to use EUPATI material to run a non-for-profit workshop/training. I want to charge workshop participants a fee to cover the costs of hosting the workshop.’ – EUPATI’s opinion: Non-commercial. You may make contributions to cover the direct cost of workshop amenities — e.g. venue, room rent, food, drink, etc., as no ‘profit’ is being made.
  • Example 3: ‘I want to use EUPATI material (or a derivative of EUPATI material) to run a workshop/training course. I want to charge participants a fee to cover the costs of the event and to make a profit. – EUPATI’s opinion: Conferences run e.g. by professional conference organisers would be considered commercial use. Please contact [email protected] to discuss your options.

The above is an easy to read summary of the license, but it does not serve as a replacement for the official legal text, which can be accessed and downloaded at https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode. Please be aware that the license may not grant you all the permissions required for your specific use case. Certain rights, such as publicity, privacy, or moral rights, might impose limitations on your material usage. Additionally, you are not obliged to adhere to the license for elements of the material already in the public domain or when your use is permitted by a relevant exception or limitation.

Unsure? Still have questions?

If you are unsure about whether your use falls under non-commercial or within the permissions of the license, please contact [email protected]. In the case of assumed commercial use, the EUPATI Consortium may propose a solution, such as deciding upon a royalty-based release.

 

Find Out More